Integrating Support Services and Caregiver Roles in mCRC Care

EP: 1.Navigating Beyond FOLFOX/FOLFIRI: Key Therapies in Advanced mCRC

EP: 2.Real-World Impact of SUNLIGHT Outcomes in mCRC

EP: 3.Fruquintinib in mCRC: Key Insights From FRESCO-2

EP: 4.Comparing mCRC Therapies: FTD/TPI Plus Bevacizumab, Fruquintinib, and Regorafenib

EP: 5.Optimizing mCRC Therapy Sequencing: Key Considerations and Future Directions

EP: 6.Guiding Patients Through Third-Line mCRC Therapy Decisions

EP: 7.Navigating Toxicity: Comparing Third-Line mCRC Therapies

EP: 8.Evaluating Quality of Life and Adherence With mCRC Treatment Options

Now Viewing

EP: 9.Integrating Support Services and Caregiver Roles in mCRC Care

EP: 10.mCRC Treatment Access: IRA Cost Cap Impact and Final Insights

Video content above is prompted by the following:

1. To set the stage, what are some of the psychological and emotional aspects of treatment decision-making with patients entering the third-line stage of metastatic colorectal cancer?
2. What are your recommendations for involving support services (such as social work or palliative care) to help patients navigate the psychosocial components of metastatic colorectal cancer (mCRC), and at what point in a patient’s care journey does this begin?
3. What is the role of the caregiver in advanced mCRC in supporting a patient through these psychosocial components?